|
DE1073471B
(de)
|
1958-09-02 |
1960-01-21 |
Chemische Werke Hüls Aktiengesellschaft, Marl (Kr. Recklinghausen) |
Verfahren zur Herstellung von Azelainsäure
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
GB1573212A
(en)
*
|
1976-04-15 |
1980-08-20 |
Technicon Instr |
Immunoassay for gentamicin
|
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4318980A
(en)
|
1978-04-10 |
1982-03-09 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a cycling reactant as label
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
SE455445B
(sv)
|
1984-08-28 |
1988-07-11 |
Pharmacia Ab |
Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik
|
|
EP0173648A3
(en)
|
1984-08-30 |
1988-04-27 |
Ciba-Geigy Ag |
New monoclonal antibodies to glycoconjugates, processes for their production, and applications
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
*
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US6548640B1
(en)
*
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5567610A
(en)
*
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
US4816450A
(en)
*
|
1986-09-15 |
1989-03-28 |
Duke University |
Inhibition of protein kinase C by long-chain bases
|
|
US4937232A
(en)
*
|
1986-09-15 |
1990-06-26 |
Duke University |
Inhibition of protein kinase C by long-chain bases
|
|
JP3101690B2
(ja)
*
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5204244A
(en)
|
1987-10-27 |
1993-04-20 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
DE3741056A1
(de)
*
|
1987-12-04 |
1989-08-24 |
Behringwerke Ag |
Manumycin-derivate, verfahren zu ihrer herstellung und ihre verwendung
|
|
ATE135397T1
(de)
|
1988-09-23 |
1996-03-15 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
|
GB8823869D0
(en)
*
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US20040049014A1
(en)
|
1988-12-28 |
2004-03-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
US5137919A
(en)
*
|
1990-12-31 |
1992-08-11 |
Biomembrane Institute |
Effect of N,N,N,-trimethylsphingosine on protein kinase C activity melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation
|
|
US5151360A
(en)
*
|
1990-12-31 |
1992-09-29 |
Biomembrane Institute |
Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation
|
|
US5248824A
(en)
*
|
1990-12-31 |
1993-09-28 |
The Biomembrane Institute |
Method of preparing N,N,N-trimethylsphingosine
|
|
US5677288A
(en)
*
|
1991-05-15 |
1997-10-14 |
Cypros Pharmaceutical Corporation |
Use of aminoglycosides to protect against excitotoxic neuron damage
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US5430160A
(en)
*
|
1991-09-23 |
1995-07-04 |
Florida State University |
Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
|
|
US5565332A
(en)
*
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
US5753229A
(en)
*
|
1991-09-25 |
1998-05-19 |
Mordoh; Jose |
Monoclonal antibodies reactive with tumor proliferating cells
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
|
US5777085A
(en)
|
1991-12-20 |
1998-07-07 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with GPIIB/IIIA
|
|
WO1993016177A1
(en)
*
|
1992-02-11 |
1993-08-19 |
Cell Genesys, Inc. |
Homogenotization of gene-targeting events
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
US6129914A
(en)
*
|
1992-03-27 |
2000-10-10 |
Protein Design Labs, Inc. |
Bispecific antibody effective to treat B-cell lymphoma and cell line
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5260288A
(en)
*
|
1992-04-03 |
1993-11-09 |
The Biomembrane Institute |
Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives
|
|
US5369030A
(en)
*
|
1992-09-11 |
1994-11-29 |
Duke University |
Method of inducing cellular differentiations and altering cell phenotype using ceramide analogs
|
|
GB9223377D0
(en)
|
1992-11-04 |
1992-12-23 |
Medarex Inc |
Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
|
|
US6210671B1
(en)
*
|
1992-12-01 |
2001-04-03 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
|
US5444087A
(en)
*
|
1993-10-19 |
1995-08-22 |
Bristol-Myers Squibb Company |
Manumycin compounds
|
|
JPH09505058A
(ja)
*
|
1993-11-15 |
1997-05-20 |
ベイカー・メディカル・リサーチ・インスティテュート |
心機能不全の治療方法およびそのために有用な医薬組成物
|
|
GB9325182D0
(en)
*
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
|
JPH09508900A
(ja)
|
1994-02-02 |
1997-09-09 |
ザ リポソーム カンパニー、インコーポレーテッド |
薬理学的に活性な化合物及びリポソーム並びにそれらの使用方法
|
|
US5430169A
(en)
|
1994-02-14 |
1995-07-04 |
The United States Of America Represented By The Department Of Health And Human Services |
Method for preparation of sphingoid bases
|
|
US5585476A
(en)
*
|
1994-02-15 |
1996-12-17 |
Maclennan; Alexander J. |
Molecular cloning and expression of G-protein coupled receptors
|
|
US5627171A
(en)
*
|
1994-04-11 |
1997-05-06 |
Oncomembrane, Inc. |
Sphingosine-1-phosphate/trimethylsphingosine composition
|
|
US5534615A
(en)
*
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
US6323201B1
(en)
*
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US7060808B1
(en)
|
1995-06-07 |
2006-06-13 |
Imclone Systems Incorporated |
Humanized anti-EGF receptor monoclonal antibody
|
|
US5667337A
(en)
*
|
1995-09-15 |
1997-09-16 |
Lazes; Richard J. |
Rotating containment and repelling boom and method for confining a material floatable on a liquid surface
|
|
US5916911A
(en)
*
|
1995-09-20 |
1999-06-29 |
The Regents Of The University Of Michigan |
Amino ceramide--like compounds and therapeutic methods of use
|
|
JPH09110722A
(ja)
|
1995-10-20 |
1997-04-28 |
Toray Ind Inc |
抗腫瘍活性物質の腫瘍細胞内導入用イムノリポソーム及びその調製法
|
|
US5882644A
(en)
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
|
US5834597A
(en)
*
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US5830916A
(en)
|
1996-05-23 |
1998-11-03 |
Duke University |
Inhibitor of ceramidase
|
|
DE19621038A1
(de)
*
|
1996-05-24 |
1997-11-27 |
Boehringer Ingelheim Kg |
Aminoguanidine, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
|
|
CA2260768C
(en)
|
1996-07-19 |
2008-06-17 |
Takara Shuzo Co., Ltd. |
Methods for producing sphingolipids and sphingolipid derivatives
|
|
US6013256A
(en)
*
|
1996-09-24 |
2000-01-11 |
Protein Design Labs, Inc. |
Method of preventing acute rejection following solid organ transplantation
|
|
US6140060A
(en)
*
|
1996-12-12 |
2000-10-31 |
Chun; Jerold J. M. |
Cloned lysophosphatidic acid receptors
|
|
US5919687A
(en)
|
1996-12-24 |
1999-07-06 |
John Hopkins University |
Recombinant N-SMases and nucleic acids encoding same
|
|
JP5264026B2
(ja)
*
|
1997-06-10 |
2013-08-14 |
エルパス・インコーポレイテッド |
心疾患の早期発見のための方法
|
|
US5989803A
(en)
*
|
1997-09-05 |
1999-11-23 |
The Trustees Of Columbia University In The City Of New York |
Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
|
|
US6649362B2
(en)
*
|
1997-09-08 |
2003-11-18 |
Medvet Science Pty. Ltd. |
Screening method for an agent having an effect on a sphingosine kinase signaling pathway
|
|
US6423527B1
(en)
*
|
1997-09-29 |
2002-07-23 |
Children's Hospital Medical Center Of Northern California |
Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
|
|
DK1034298T3
(da)
|
1997-12-05 |
2012-01-30 |
Scripps Research Inst |
Humanisering af murint antistof
|
|
US6057126A
(en)
*
|
1997-12-24 |
2000-05-02 |
Allelix Biopharmaceuticals, Inc. |
Mammalian EDG-5 receptor homologs
|
|
EP1060256A1
(en)
*
|
1998-01-29 |
2000-12-20 |
Smithkline Beecham Plc |
Novel sphingosine-1 phosphate lyase
|
|
DE69943314D1
(de)
*
|
1998-02-12 |
2011-05-12 |
Kapil N Bhalla |
Sphingolipid-derivate und verfahren zu deren verwendung
|
|
JP2002508940A
(ja)
*
|
1998-03-13 |
2002-03-26 |
デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド |
ヒト化抗体およびその使用
|
|
US6130067A
(en)
*
|
1998-05-20 |
2000-10-10 |
Smithkline Beecham Corporation |
Human EDG3sb gene
|
|
JP2000029318A
(ja)
|
1998-07-15 |
2000-01-28 |
Ricoh Co Ltd |
液体現像装置
|
|
AU4724599A
(en)
*
|
1998-06-29 |
2000-01-17 |
Children's Hospital Of Los Angeles |
Treatment of hyperproliferative disorders
|
|
HK1044159A1
(zh)
|
1998-12-01 |
2002-10-11 |
蛋白质设计实验室股份有限公司 |
抗γ-干扰素的人化抗体
|
|
JP2000293181A
(ja)
|
1999-04-12 |
2000-10-20 |
Daiichikosho Co Ltd |
歌詞画像描出機能に特徴を有するカラオケ装置
|
|
US6342219B1
(en)
*
|
1999-04-28 |
2002-01-29 |
Board Of Regents, The University Of Texas System |
Antibody compositions for selectively inhibiting VEGF
|
|
US6306911B1
(en)
*
|
2000-02-07 |
2001-10-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as neutral sphingomyelinase inhibitors
|
|
JP2001261575A
(ja)
*
|
2000-03-13 |
2001-09-26 |
General Hospital Corp |
血管収縮を調節する方法とその組成物
|
|
US6571638B2
(en)
|
2000-06-30 |
2003-06-03 |
Sawtek, Inc. |
Surface-acoustic-wave pressure sensor and associated methods
|
|
US20030125533A1
(en)
*
|
2000-10-06 |
2003-07-03 |
Sophia Kossida |
Regulation of human sphingosine kinase-like protein
|
|
CA2432978C
(en)
*
|
2000-12-22 |
2012-08-28 |
Medlyte, Inc. |
Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
|
|
US20020150582A1
(en)
*
|
2001-02-08 |
2002-10-17 |
Friedrichs Gregory S. |
Method of treating or inhibiting cellular injury or cell death
|
|
US7674580B2
(en)
*
|
2002-01-17 |
2010-03-09 |
Children's Hospital & Research Center At Oakland |
Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
|
|
PT1505959E
(pt)
*
|
2002-05-16 |
2009-02-05 |
Novartis Ag |
Utilização de agentes de ligação do receptor edg em cancro
|
|
US7794713B2
(en)
*
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
|
DK1812797T3
(da)
|
2004-10-28 |
2013-05-21 |
Lpath Inc |
Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdomme
|
|
US20110123440A1
(en)
|
2005-03-29 |
2011-05-26 |
Genevieve Hansen |
Altered Antibody FC Regions and Uses Thereof
|
|
US20080213274A1
(en)
*
|
2005-10-28 |
2008-09-04 |
Sabbadini Roger A |
Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
|
|
US7862812B2
(en)
*
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
|
US8614103B2
(en)
*
|
2006-10-27 |
2013-12-24 |
Lpath, Inc. |
Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions
|
|
PL2087002T3
(pl)
*
|
2006-10-27 |
2015-02-27 |
Lpath Inc |
Kompozycje i sposoby do wiązania sfingozyno-1 fosforanu
|
|
EP2563395A4
(en)
*
|
2010-04-30 |
2013-11-27 |
Lpath Inc |
TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES
|
|
JP2013543479A
(ja)
*
|
2010-06-06 |
2013-12-05 |
エルパス・インコーポレイテッド |
抗ｓ１ｐ抗体およびスフィンゴ脂質経路阻害剤の組み合わせ
|